Cargando…

Anti-Inflammatory Effects of Arsenic Trioxide Eluting Stents in a Porcine Coronary Model

Previous research from our group has demonstrated arsenic trioxide eluting stents significantly reduced neointimal area and thickness compared with bare metal stents. In the present study, the anti-inflammatory effects of arsenic trioxide in vitro and arsenic trioxide eluting stents in a porcine cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Li, Gong, Feirong, Tian, Wenjie, Li, Weiming, Zhang, Feng, Qian, Juying, Sun, Aijun, Zou, Yunzeng, Yang, Wei, Ge, Junbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581093/ https://www.ncbi.nlm.nih.gov/pubmed/23509814 http://dx.doi.org/10.1155/2013/937936

Ejemplares similares

Nine-month Angiographic and Two-year Clinical Follow-up of Novel Biodegradable-polymer Arsenic Trioxide-eluting Stent Versus Durable-polymer Sirolimus-eluting Stent For Coronary Artery Disease
por: Shen, Li, et al.
Publicado: (2015)

Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization
por: Ma, Jianying, et al.
Publicado: (2012)

Comparison of Acute Recoil between Bioabsorbable Poly-L-lactic Acid XINSORB Stent and Metallic Stent in Porcine Model
por: Wu, Yizhe, et al.
Publicado: (2012)

Three-year clinical outcomes of a sirolimus-eluting bioresorbable scaffold (XINSORB) and a metallic stent to treat coronary artery stenosis
por: Wu, Yizhe, et al.
Publicado: (2020)

Nanoporous CREG-Eluting Stent Attenuates In-Stent Neointimal Formation in Porcine Coronary Arteries
por: Deng, Jie, et al.
Publicado: (2013)

Proteomics Analysis of Myocardial Tissues in a Mouse Model of Coronary Microembolization
por: Chen, Ao, et al.
Publicado: (2018)

A novel mechanism of inhibiting in-stent restenosis with arsenic trioxide drug-eluting stent: Enhancing contractile phenotype of vascular smooth muscle cells via YAP pathway
por: Zhao, Yinping, et al.
Publicado: (2020)

Long-term effect of stents eluting 6-mercaptopurine in porcine coronary arteries
por: Ruiter, Matthijs S., et al.
Publicado: (2016)

High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells
por: Lu, Hao, et al.
Publicado: (2013)

Everolimus-eluting coronary stents
por: Saez, Alejandro, et al.
Publicado: (2010)

Szabo 2-stent technique for coronary bifurcation lesions: procedural and short-term outcomes
por: Yang, Hongbo, et al.
Publicado: (2020)

Five-year comparative study of thin-strut rapamycin-eluting bioabsorbable scaffold with metallic drug-eluting stent in porcine coronary artery
por: Liu, Yaokun, et al.
Publicado: (2022)

Left ventricular remodeling with preserved function after coronary microembolization: the effect of methylprednisolone
por: Ma, Jianying, et al.
Publicado: (2014)

Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation
por: Chen, Ao, et al.
Publicado: (2021)

Histopathological Comparison among Biolimus, Zotarolimus and Everolimus-Eluting Stents in Porcine Coronary Restenosis Model
por: Lim, Kyung Seob, et al.
Publicado: (2013)

Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries
por: Sperling, Christian, et al.
Publicado: (2019)

Effect of Rivaroxaban and Clopidogrel Combination Therapy on In-Stent Responses After Everolimus-Eluting Stent Implantation in a Porcine Coronary Model
por: Kitano, Daisuke, et al.
Publicado: (2022)

A novel method to delivery stem cells to the injured heart: spatially focused magnetic targeting strategy
por: Huang, Zheyong, et al.
Publicado: (2012)

The antitumor effect of arsenic trioxide on hepatocellular carcinoma is enhanced by andrographolide
por: Duan, Xuhua, et al.
Publicado: (2017)

Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans
por: Chen, Xueying, et al.
Publicado: (2011)

Inverse Relationship between Serum VEGF Levels and Late In-Stent Restenosis of Drug-Eluting Stents
por: Yin, Jiasheng, et al.
Publicado: (2017)

microRNA-181a represses ox-LDL-stimulated inflammatory response in dendritic cell by targeting c-Fos
por: Wu, Chaoneng, et al.
Publicado: (2012)

In silico mechanisms of arsenic trioxide-induced cardiotoxicity
por: Li, Yacong, et al.
Publicado: (2022)

Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011)

Protective effect of resveratrol on arsenic trioxide-induced nephrotoxicity in rats
por: Zhang, Weiqian, et al.
Publicado: (2014)

Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model
por: Watt, Jonathan, et al.
Publicado: (2013)

Biosafety and efficacy evaluation of a biodegradable magnesium-based drug-eluting stent in porcine coronary artery
por: Zhu, Jinzhou, et al.
Publicado: (2021)

Combination of CD34-positive cell subsets with infarcted myocardium-like matrix stiffness: a potential solution to cell-based cardiac repair
por: Zhang, Shuning, et al.
Publicado: (2014)

Drug eluting stents: Focus on Cypher™ sirolimus-eluting coronary stents in the treatment of patients with bifurcation lesions
por: Chieffo, Alaide, et al.
Publicado: (2007)

Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
por: Jafaripour, Iraj, et al.
Publicado: (2023)

Sirolimus-eluting coronary stents: a review
por: Abizaid, Alexandre
Publicado: (2007)

Final report of the 5-year clinical outcomes of the XINSORB bioresorbable sirolimus-eluting scaffold in the treatment of single de novo coronary lesions in a first-in-human study
por: Wu, Yizhe, et al.
Publicado: (2020)

Timing for intracoronary administration of bone marrow mononuclear cells after acute ST-elevation myocardial infarction: a pilot study
por: Huang, Rongchong, et al.
Publicado: (2015)

Everolimus-Eluting Biodegradable Abluminal Coating Stent versus Durable Conformal Coating Stent: Termination of the Inflammatory Response Associated with Neointimal Healing in a Porcine Coronary Model
por: Mori, Masayuki, et al.
Publicado: (2020)

Randomized clinical trial comparing abluminal biodegradable polymer sirolimus-eluting stents with durable polymer sirolimus-eluting stents: Nine months angiographic and 5-year clinical outcomes
por: Zhang, Haijun, et al.
Publicado: (2016)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

Evidences of Protective Potentials of Microdoses of Ultra-High Diluted Arsenic Trioxide in Mice Receiving Repeated Injections of Arsenic Trioxide
por: Banerjee, Pathikrit, et al.
Publicado: (2011)

The Protective Role of Resveratrol against Arsenic Trioxide-Induced Cardiotoxicity
por: Zhang, Weiqian, et al.
Publicado: (2013)

Prospective multicentre open-label randomised controlled trial of 3-month versus 12-month dual antiplatelet therapy after implantation of the new generation biodegradable polymer sirolimus TARGET-eluting coronary stent: protocol of the TARGET DAPT trial
por: Yang, Hongbo, et al.
Publicado: (2019)

Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_2l57qo5mh9vvel0m6avm8ooomn